Sort
261,768 grants matching “gene therapy”
Overcoming Drug Resistance in Multiple Myeloma
$1,180,311Peter Leif Bergsagel · Mayo Clinic Arizona · U54 · FY2020 · CA
Establishing the POROS Intracellular Delivery System as a Platform for Cellular Therapeutics
$1,180,225Michael M Binkley · Opencell Technologies, Inc. · R44 · FY2022 · CA
Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies
$1,180,007Luis Manuel Branco · Zalgen Labs, Llc · R01 · FY2023 · AI
CB1 Neutral Antagonists for Alcohol Use Disorder
$1,179,935Alexandros Makriyannis · Northeastern University · U01 · FY2024 · AA
Parasitic Ulcer Treatment Trial
$1,179,904Jeremy David Keenan · University Of California, San Francisco · UG1 · FY2024 · EY
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
$1,179,894Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Mayo Center for Cell Signaling in Gastroenterology
$1,179,780Nicholas F. Larusso · Mayo Clinic Rochester · P30 · FY2023 · DK
TIM recognition of phosphatidylserine regulates innate and adaptive immunity
$1,179,735Gordon James Freeman · Dana-Farber Cancer Inst · P01 · FY2014 · AI
Clinical Investigations of Sjogren's Syndrome
$1,179,709Gabor Illei · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE
Liver Pathobiology and Gene Therapy Research Core Center
$1,179,692David A Shafritz · Albert Einstein College Of Medicine · P30 · FY2008 · DK
Liver Pathobiology and Gene Therapy Research Core Center
$1,179,692David A Shafritz · Albert Einstein College Of Medicine · P30 · FY2007 · DK
HyperGEN: Genetics of Left Ventricular Hypertrophy
$1,179,645Donna K. Arnett · University Of Alabama At Birmingham · R01 · FY2014 · HL
Resource for Molecular Imaging Agents in Precision Medicine
$1,179,527Martin G Pomper · Johns Hopkins University · P41 · FY2021 · EB
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers
$1,179,389Vishwas Paralkar · Cybrexa, Inc. · R44 · FY2020 · CA
Factors Influencing Genetic Transcription Initiation And Termination
$1,179,326Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
SLEEP, AGING AND CIRCADIAN RHYTHM DISORDERS
$1,179,224Brigham And Women'S Hospital · P01 · FY2001 · AG
Retroviral genetic modification of PBLs to optimize expansion for cell therapy
$1,179,214Nicholas Klemen · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Development Of New Chemotherapeutics For Tuberculosis
$1,179,135Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Texas NeuroAIDS Research Center
$1,179,094Benjamin B. Gelman · University Of Texas Med Br Galveston · U24 · FY2013 · MH
Interventional approaches for restoring vision
$1,179,048Anand Swaroop · National Eye Institute · ZIA · FY2009 · EY
Growth Regulation and Therapy of Leukemias and Lymphomas
$1,179,037University Of Kentucky · P01 · FY2005 · CA
Biosynthesis, Processing And Secretion Of Neuropeptides And Pituitary Hormones
$1,179,030Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · Z01 · FY2008 · HD
Dermatology Consultation Service
$1,179,005Edward Cowen · Division Of Basic Sciences - Nci · ZID · FY2010 · CA
Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients
$1,178,998Ravi Kumar Anchoori · Up Therapeutics, Inc. · R44 · FY2024 · CA
Molecular therapy for CF and genetic diseases
$1,178,972James M Wilson · University Of Pennsylvania · P30 · FY2010 · DK